Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0620920220540050613
Experimental & Molecular Medicine
2022 Volume.54 No. 5 p.613 ~ p.625
The optimized core peptide derived from CABIN1 efficiently inhibits calcineurin-mediated T-cell activation
Lee Sang-Ho

Lee Han-Teo
Kim Young-Ah
Lee Il-Hwan
Kang Seong-Jun
Sim Kyeong-Pyo
Park Chung-Gyu
Choi Kyung-Ho
Youn Hong-Duk
Abstract
The C-terminal fragment of CABIN1 interacts with calcineurin and represses the transcriptional activity of the nuclear factor of activated T cells (NFAT). However, the specific sequences and mechanisms through which it binds to calcineurin are unclear. This study determined that decameric peptide (CABIN1 residues 2146?2155) is minimally required for binding to calcineurin. This peptide contains a unique ¡°PPTP¡± C-terminal sequence and a ¡°PxIxIT¡± N-terminal motif. Furthermore, p38MAPK phosphorylated the threonine residue of the ¡°PPTP¡± sequence under physiological conditions, dramatically enhancing the peptide¡¯s binding affinity to calcineurin. Therefore, the CABIN1 peptide inhibited the calcineurin-NFAT pathway and the activation of T cells more efficiently than the VIVIT peptide without affecting calcineurin¡¯s phosphatase activity. The CABIN1 peptide could thus be a more potent calcineurin inhibitor and provide therapeutic opportunities for various diseases caused by the calcineurin-NFAT pathway.
KEYWORD
Cell death and immune response, Protein?protein interaction networks
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø